Navigation Links
Benjamin Custodio Joins Millennium Biotechnologies to Expand International Sales
Date:10/28/2008

iate increase in our overseas sales at enhanced profit margins."

According to newly elected board member, Benjamin Custodio, "Millennium Biotechnologies is emerging as a leader in the development of targeted nutritional products in the Clinical, Long Term Care, and Sports markets. With the recent launch of the Company's ready-to-drink products, Resurgex Essential and Resurgex Essential Plus, now is the time for aggressive international expansion. I look forward to working with the Company in leveraging my international contacts for the benefit of its shareholders and believe that numerous overseas expansion opportunities exist in the very near term."

About Millennium

Millennium Biotechnologies is a leader in the development, of targeted nutritional products in the Clinical Nutrition Market and Sports Nutrition Market. Millennium's six marketed products form an advanced line of nutritional formulas. Resurgex Select(R) is a whole foods-based, calorically dense, high-protein nutritional formula developed for cancer patients undergoing chemotherapy or radiation treatments. Resurgex(R) and Resurgex Plus(R) are specialized, anabolic nutritional supplements rich in antioxidants that provide nutritional support post-treatment. Millennium also created Surgex(TM) sports nutrition formula to address the nutritional concerns of professional, Olympic, and amateur elite athletes. These athletes often experience similar symptoms post-workout to those battling immuno-compromised conditions, such as fatigue, loss of lean muscle, oxidative stress, and reduced immune function. Resurgex Essential(TM) and Resurgex Essential Plus(TM) are comprehensive, calorically dense formulas that meet and succeed the nutritional requirements of the assisted living community.

Statements in this news release regarding future financial and operating results, future growth in R&D programs, potential applications of the Millennium's technology, opportunities for the Millennium,
'/>"/>

SOURCE Millennium Biotechnologies Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Jerome Wilson Joins PRA Internationals Late Phase Service Group
2. Sir Richard Sykes Joins BioCeramic Therapeutics as Chairman
3. Leading Heart Specialist Joins Duska Therapeutics as Scientific Consultant
4. Karen Walton-Bowen Joins Abt Bio-Pharma Solutions, Inc., as Senior Director, Biometrics
5. Food and Beverage Giant Joins Kannapolis Research Center
6. Mark Sutherland Joins GenVault as Senior Vice President, Business Development
7. Chief Technology Officer Joins ACAMP
8. Charles C. Harwood, Jr., Joins Cellectar, Inc.s Board of Directors
9. Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines
10. David Hsia, Ph.D. Joins Kinex Pharmaceuticals Board of Directors
11. Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... 9 For more than 20 years,research...velopment of a,Brain-Computer Interface (BCI). Thi...ain and a computer. Such a system enables complete... devices in their environment just by,mental activ... supervised by,the researchers themselves to use s...
(Date:11/9/2009)...e is a research industry first, allowing veterinar...rch safety study data to be managed in one softwar...olls, NJ (PRWEB) November 9, 2009 -- Xybion Medica...stima™ VM, an integrated enterprise software...se and care of veterinary research subjects. Prist...
(Date:11/6/2009)...all/ - Microbix Biosystems Inc. (the "Company") an...F1 Certification of Annual Filings of William Gast...e Chief Financial Officer (the "Officer,s Certific...he annual audited financial statements for the yea...ially filed the annual financial statements for th...
(Date:11/6/2009)...ire-FirstCall/ -- ,, 3Q09 Corporate Highligh.... Marketing Authorization to Astellas Pharma Europ...eadiness activities Expanded management team to i...irector, Commercial Operations Appointed Bradford...ee chairman , Upcoming 2009 Milestones: ,...
Breaking Biology Technology:intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10
...I-COR Biosciences has released a,new Technical Not...y Infrared,Imaging System. The E-PAGE 48- and 96-...on, Carlsbad, CA) provide a high-throughput SDS-PA...ed in conjunction with the,iBlot(TM) Dry Blotting ...,electrophoresed and transferred to a membrane in ...
...harmAthene, Inc.,(NYSE Alternext US: PIP), a biode...gainst biological and chemical threats, announced ... Pharma Ltd., to commercialize its,biodefense prod...ical countermeasures to combat the risk of,terrori...a significant global,concern," stated David P. Wri...
... Jazz Pharmaceuticals,Inc. (Nasdaq: JAZZ ) anno...tion,planned for today at the Lazard Capital Marke...ximity of the release of preliminary top-line data...f JZP-6 (sodium oxybate) for,the treatment of fibr...will release the preliminary top-line data,within ...
Other Biology Technology:Technical Note: E-PAGE(TM) 48- and 96-Well Gels on the Odyssey(R) Infrared Imaging System 2PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel 2PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel 3PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel 4
(Date:11/9/2009)...ed in California and elsewhere provide support for... fisheries and protecting marine habitats, accordi...Santa Cruz. , A recent study in the Gulf of Cal...key concept behind marine reserves--the idea that ...sh the stocks of harvested species outside the res...
(Date:11/9/2009)...partment of Energy (DOE) has announced plans to fu...gham (UAB) School of Engineering on technologies t...ough the capture and permanent safe storage, or se...is in collaboration with Southern Company, the par...E through the 2009 American Recovery and Reinvestm...
(Date:11/9/2009)...PRNewswire/ -- Genencor, a division of Danisco, ha... the American Institute of Chemical Engineers (AIC...r cellulosic ethanol. Yesterday, Robert Davis, Cha...ard to Landon Steele, who is Marketing Director, B...er, and Aaron Kelley, who is Senior Engineer, Biom...
Breaking Biology News(10 mins):Studies show marine reserves can be an effective tool for managing fisheries 2Studies show marine reserves can be an effective tool for managing fisheries 3Studies show marine reserves can be an effective tool for managing fisheries 4Studies show marine reserves can be an effective tool for managing fisheries 5UAB, partners seek safe carbon dioxide storage for 'greener' power generation 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 3Genencor Wins The American Institute of Chemical Engineers (AIChE) Sustainable Energy Award For Accellerase(R) Cellulosic Ethanol Enzymes 2AstraZeneca Among Working Mother Magazines 2009 Best Companies 58005 1AstraZeneca Among Working Mother Magazines 2009 Best Companies 58005 2AstraZeneca Among Working Mother Magazines 2009 Best Companies 58005 3Caring Candles Embrace Caregivers and Help Spread the Light 58003 1Caring Candles Embrace Caregivers and Help Spread the Light 58003 2Hard To Treat Diseases 28HTDS 29 Delivers Varicella Vaccine To Guatemala 58001 1Hard To Treat Diseases 28HTDS 29 Delivers Varicella Vaccine To Guatemala 58001 2Hard To Treat Diseases 28HTDS 29 Delivers Varicella Vaccine To Guatemala 58001 3
...em cells collected from human corneas restore tran...en injected into eyes that are scarred and hazy, a...rchers at the University of Pittsburgh School of M...nal Stem Cells and appears online today. , The ...e an effective way to treat human corneal blindnes...
...al field stations have long been home to a rich le...hem important places for serendipitous discoveries...In a paper published in the April issue of the jou... National Science Foundation,s (NSF) Long Term Eco...tate that few people realize the value of the data...
...struction of complex man-made objects--a car, for ...s what are known as "top-down" processes, in which...is imposed from the outside (say, by an automobile..., "Top-down approaches have been extremely succes...te of Technology (Caltech). "But as the object bei...
Other Biology News:Stem cell therapy makes cloudy corneas clear, according to Pitt researchers 2Field stations foster serendipitous discoveries in environmental, biological sciences 2Field stations foster serendipitous discoveries in environmental, biological sciences 3Caltech scientists control complex nucleation processes using DNA origami seeds 2Caltech scientists control complex nucleation processes using DNA origami seeds 3
Anti-Ezrin / Radixin / Moesin Antibody, Unconjugated from CHEMICON
Rat Anti-Mouse ABCA1 Monoclonal Antibody, Unconjugated, Clone 5A1-1422.11 from ABR-Affinity BioReagents
Goat Anti-Human SART3 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Hamartin Monoclonal Antibody, Unconjugated, Clone 1B2 from Cell Signaling Technology
Biology Products: